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Leukocyte migration: Scent of the T zone
Jason G. Cyster
Recent studies show that the chemokine receptor CCR7
helps T lymphocytes and dendritic cells to navigate into
the T-cell zone of lymphoid organs. Furthermore, down-
modulation of CCR7 redirects some activated T cells from
these zones into other lymphoid tissue compartments.
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Most adaptive immune responses are initiated when
antigen-specific T cells encounter antigen-bearing dendritic
cells inside secondary lymphoid organs. As the frequency of
T cells specific for any given antigen is very low, it is impor-
tant that individual dendritic cells can easily meet with
many potential T-cell suitors. This is achieved by the colo-
calization of dendritic cells and T cells in specific regions of
lymph nodes and the spleen known as T zones, which can
be thought of as meeting places for T cells and dendritic
cells. After entering the lymph nodes or spleen, T cells
migrate through the T zone and search out dendritic cells.
Similarly, entering dendritic cells migrate quickly into the
depths of the T zone and contact multiple T cells. Even
without knowing more than this, one might speculate that
the cells are coming together by responding to the same
attractive cues. Yet, while much has been learnt about how
cells leave the blood and enter the lymphoid organs [1],
little was known until recently about which signals directed
cells into the T zone. Rapid progress has now clearly shown
that the chemokine receptor CCR7 and its chemokine
ligands recruit lymphocytes and dendritic cells into lym-
phoid T zones [2,3]. 
Naïve T cells — that is, those that have not yet
responded to antigen — enter the lymph nodes from the
blood across high endothelial venules while antigen-
bearing dendritic cells enter predominantly by afferent
lymphatic vessels (Figure 1). In the spleen, both cell types
enter from the blood. The mechanism of cell migration to
the T zones of these lymphoid organs began to unfold
with the discovery of two chemokines of the C–C class
that are efficacious attractants of naïve T cells. Termed
SLC/6Ckine/Exodus2/TCA4 and ELC/MIP3β/CKβ-11
(hereafter SLC and ELC, respectively), their genes colo-
calize on mouse chromosome 4 and they are more related
to each other than to other chemokines [4,5]. SLC differs
from ELC, however, in that it contains an additional 30
amino acid domain at the carboxyl terminus that is highly
basic. SLC is produced by high endothelial venules and
by stromal cells distributed through T zones [5]. ELC is
also expressed in cells throughout the T zone but does not
appear to be produced by high endothelial venules [5].
During its primary characterization, ELC had been identi-
fied as a ligand for CCR7, and subsequently SLC was also
found to bind this receptor [4,5]. 
The next important development in SLC/ELC biology
was the discovery of a spontaneous mutant mouse line
that lacked measurable levels of SLC expression in lym-
phoid tissue [2]. ELC could still be detected, but at levels
several-fold below those found in normal mice [2]. This
mutant line had been named plt, for paucity of lymph
node T cells, and had been shown to have greatly reduced
migration of T cells into lymph nodes and Peyer’s
patches, the regions of lymphoid tissue in the small intes-
tine [6]. T cells also did not accumulate in the white pulp
of spleen where lymphocytes are normally located, instead
appearing around the sinuses in the red pulp where red
blood cells are usually found. Genetic mapping studies
placed the plt locus in the same region of chromosome 4 as
the genes for SLC and ELC, but the genetic analysis
turned out to be complex and initially no mutation of SLC
was found [2,6]. 
An explanation is now in hand with the discovery that
there are two genes encoding mouse SLC [7]. The identi-
fied genes encode proteins differing by only two amino
acids and the two forms appear to have equivalent activity,
consistent with the fact that only one sequence for SLC
has been identified in humans [7]. But the two mouse
genes differ in their expression pattern: one is expressed
at high levels in lymphoid organs, including high endothe-
lial venules, and this is the gene deleted in plt mice [7];
the second is expressed predominantly in non-lymphoid
organs and continues to be expressed in plt mice. Since
most of the SLC signal detected in non-lymphoid organs
comes from lymphatic endothelium, it seems likely that
the remaining SLC gene in plt animals is expressed at this
site. What is still unclear is the size of the genomic dele-
tion in the plt strain, and whether additional genes are lost.
Given the complexity of the plt locus, the characterization
of CCR7-deficient mice has been keenly anticipated. The
wait is now over, with a recent report in Cell describing
mice with a targeted mutation of the CCR7 gene [3]. The
first obvious question has been immediately answered —
the mice have a striking paucity of lymph node T cells [3].
When T cells from these CCR7-deficient mice are trans-
ferred to wild-type recipients, they home very poorly into
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lymph nodes and Peyer’s patches, indicating a defect in
recruitment across high endothelial venules. Taken
together with the constitutive production of SLC by high
endothelial venules, the failure of T cells to home nor-
mally to lymph nodes in plt mice, and the ability of SLC to
promote shear-resistant adhesion of T cells via integrin
activation [8,9], it can be concluded that CCR7 and SLC
are important for promoting integrin-mediated arrest of
lymphocytes on high endothelial venules. Although a role
for ELC in this process has not yet been excluded, it
seems most likely that SLC has evolved to serve this func-
tion with the additional domain at the carboxyl terminus
helping to tether the molecule to proteoglycans at the
high endothelial venule surface (Figure 1). 
Further examination of the lymphoid organs of the
CCR7-deficient mice revealed additional defects. Within
the lymph nodes of these mice, T cells are sparsely dis-
tributed and many cells are mislocated near the subcapsu-
lar sinus around the edge of the lymph node, or in areas
normally occupied by B cells [3]. In the spleen, T cells
continue to accumulate but they largely fail to enter the
T-cell compartment, appearing instead within the red
pulp. CCR7 and its ligands are therefore essential for the
normal migration of naïve T cells to the T zones of sec-
ondary lymphoid organs. 
Maturing dendritic cells also migrate into T zones and the
discovery that they upregulate CCR7 and become
responsive to ELC and SLC (reviewed in [10]), together
with the finding that SLC is made by lymphatic vessels,
led to a seemingly simple model. Immature dendritic
cells (for example, Langerhans’ cells of the skin) exposed
to noxious stimuli in the periphery begin to upregulate
CCR7 while endocytosing antigen and then are chemo-
tactically attracted to SLC-expressing lymphatic vessels.
Flowing with the lymph, the maturing dendritic cells
pour into the subcapsular sinus of the draining node and
then follow a gradient of both SLC and ELC to move into
the lymphoid T zone. 
This notion was tested first in plt mice: Langerhans’ cells
were indeed found to migrate with reduced efficiency to
draining lymph nodes in these mice [2]. Entry of the
maturing Langerhans’ cells into dermal lymphatics of plt
mice was normal, however, which at first did not seem to
fit the proposal. But, with the new evidence that plt mice
continue to express SLC in peripheral tissues (presumably
in the lymphatic vessels) [7], the model has been resur-
rected. Further support has now been provided by the
finding of an almost complete block in the migration of
Langerhans’ cells to draining lymph nodes in CCR7-defi-
cient animals [3]. Before this pathway can start appearing
in textbooks, however, it remains important to measure
directly the number of CCR7-deficient dendritic cells
migrating into lymphatic vessels. It will also be interesting
to see whether the migration of other types of dendritic
cell is affected by the absence of CCR7. 
The immunological importance of CCR7 in bringing
together antigen-bearing dendritic cells and antigen-spe-
cific T cells is supported by the failure of CCR7-deficient
mice to mount a delayed-type hypersensitivity response
— a form of cell-mediated immunity elicited by antigens
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Figure 1
Model of SLC and ELC involvement in T-cell
migration into the lymph node T zone. (a) A
schematic representation of a cross-section
of a lymph node. (b) An enlarged view of a
region of the T zone near a high endothelial
venule (HEV). Red dots represent SLC, with
the irregular knob as the unique carboxy-
terminal region. Blue dots represent ELC. It
is suggested that SLC is present both on the
lumenal surface of the high endothelial
venule and within the parenchyma of the T
zone, whereas ELC is made only by cells
within the T zone. A T cell passing along the
high endothelial venule begins a rolling
interaction when L-selectin on the T cell
binds to sulfated carbohydrate ligands on
high endothelial venule glycoproteins. The
rolling T cell may then encounter SLC
presented by mucin-type molecules on the
high endothelial venule and this triggers
integrin activation and arrest of the rolling
lymphocyte. (For clarity, the diagram does
not show L-selectin, integrins or adhesion
molecules.) The T cell then actively migrates
across the endothelium into the T zone and
this is suggested to be in response to a
combination of SLC and ELC. Dendritic cells
(DC) entering via afferent lymphatics are also
attracted into the T zone by SLC and ELC.
By guiding CCR7+ T cells and dendritic cells
to a common location, SLC and ELC help to
bring cells together for the immune response.
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in the skin [3]. These mice also mount poor primary anti-
body responses [3]. Whether this defect is attributable to a
role for CCR7 in directing movements of T cells, den-
dritic cells or B cells, or a combination of these effects has
not yet been tested, although other recent findings have
established important roles for changes in CCR7 expres-
sion in redirecting the movements of helper T cells. 
Cells of the Th2 helper T-cell subtype are more effective
B-cell helpers than Th1 cells and, in a study published
recently in Science, Randolph et al. [11] demonstrate that
differences in CCR7 expression may contribute to this dif-
fering efficacy. Murine Th2 cells generated in vitro have
been found to express low levels of CCR7 and, following in
vivo transfer, they migrated to the B-cell–T-cell boundary
in the spleen [11], the site where antigen-specific T and B
lymphocytes first interact. Th1 cells, by contrast, express
significant amounts of CCR7 and migrate preferentially
into the central T zone in the spleen. Strikingly, when the
Th2 cells are forced to re-express CCR7 by retrovirus-
mediated gene transfer, they are redirected towards the
central T zone and, importantly, have a reduced ability to
act as B-cell helpers [11]. Although the different migratory
properties of the Th2 and Th1 cells are less apparent in
lymph nodes, other studies suggest that antigen-induced
decreases in responsiveness to SLC and ELC may also
contribute to T-cell migration towards follicles in lymph
nodes [12]. In another recent study, anti-viral CD8+ effec-
tor T cells were found to downregulate CCR7 and to lose
their ability to enter lymphoid regions of the spleen [13].
Modulation of the levels of CCR7 may therefore be of
general importance in redirecting cell movements in lym-
phoid organs during the immune response. 
Low responsiveness to SLC and ELC is also a feature of
the memory T-cell population and may act together with
reduced expression of the cell-adhesion molecule
L-selectin to reduce the homing of memory cells into lym-
phoid organs and thereby promote migration through
peripheral tissues [8,9]. Some memory T cells do migrate
across high endothelial venules into lymph nodes and
Peyer’s patches [14], as well as into T-cell areas of the
spleen, however [12]. Using a newly generated anti-CCR7
antibody, Sallusto et al. [15] have made the exciting
finding that memory T cells in human peripheral blood
can be divided into CCR7+ and CCR7– populations. 
CCR7+ memory cells respond to lower doses of antigen
than naïve cells and are more efficient at promoting activa-
tion of dendritic cells, suggesting that they will be highly
effective in initiating the secondary immune response
within lymphoid organs. By contrast, a defining feature of
the CCR7– memory cells is their propensity to make large
amounts of inflammatory mediators, leading to the sugges-
tion that they are ‘memory effector’ cells [15] — memory
cells that preferentially migrate into peripheral tissues and
mediate effector functions. A possible precursor–product
relationship between CCR7+ and CCR7– memory cells is
proposed [15]. These provocative findings help to bring
together a lot of somewhat discordant data on memory
T-cell migration. But memory T cells express receptors
for many different chemokines [15] and the discovery
that secondary antibody responses are normal in CCR7-
deficient mice suggests that memory cells can enter
lymph nodes efficiently even in the absence of CCR7. It
will therefore be especially important to assess the effect
of CCR7 deficiency on the trafficking properties of
memory T cells. 
In summary, CCR7 and its ligands can now be said con-
clusively to be required for normal trafficking of T lym-
phocytes and dendritic cells to lymphoid T zones. Many
questions remain, however. Foremost is the issue of the
relative roles of SLC and ELC: for example, is ELC
needed because cells become desensitized to SLC in the
process of crossing high endothelial venules or lymphatic
vessels? Given that lymph nodes of plt mice and CCR7-
deficient mice have an increased proportion of memory
cells relative to naïve cells, does this mean that SLC is not
critical for memory cell migration into lymph nodes via
afferent lymphatic vessels or high endothelial venules? A
role for ELC/SLC and CCR7 in directing movement of B
cells to the T zone is supported by studies of the CCR7-
deficient animals [3], but is this role functionally impor-
tant? Both SLC and ELC are expressed in the thymus
and CCR7 expression is increased on thymocytes as they
mature [4,5]. Is the skewed ratio of CD4:CD8 single-posi-
tive mature T cells in the peripheral blood of CCR7-defi-
cient animals [3] a hint of a thymic defect? Although ELC
and SLC are predominantly lymphoid chemokines, ELC
can become upregulated in atherosclerotic lesions [16].
What roles do these molecules play at these and other
sites of inflammation? 
Although there are a lot of questions still to be answered,
the importance of CCR7 and its ligands in bringing multi-
ple cell types together for the immune response is no
longer in doubt. So, will a CCR7 antagonist be the next
billion dollar molecule? 
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If you found this dispatch interesting, you might also want
to read the June 1999 issue of
Current Opinion in
Immunology
which included the following reviews, edited
by Peter S Linsley and Michael Reth, on
Lymphocyte activation and effector
functions:
T cell antigen-receptor signal transduction
Jeroen EM van Leeuwen and Lawrence E Samelson
Co-receptors on B lymphocytes
Takeshi Tsubata
Signal transduction from the B cell antigen-receptor
Kerry S Campbell
Membrane compartmentation and the response 
to antigen
Ramnik Xavier and Brian Seed
The regulation of antigen-receptor signaling by protein
tyrosine phosphatases: a hole in the story
Matthew L Thomas
Apoptosis signaling in lymphocytes
Carsten Scaffidi, Sabine Kirchhoff, Peter H Krammer 
and Marcus E Peter
T cell co-stimulatory molecules other than CD28
Tania H Watts and Mark A DeBenedette
CTLA-4 and T cell activation
Mariette A Oosterwegel, Rebecca J Greenwald, Didier A
Mandelbrot, Robert B Lorsbach and Arlene H Sharpe
Natural killer cell activation and inhibition by receptors
for MHC class I
Miguel López-Botet and Teresa Bellón
Developmental regulation of dendritic cell function
Peter JL Lane and Thomas Brocker
Cytotoxic T lymphocyte activation by cross-priming
William R Heath and Francis R Carbone
Chemokine receptors in lymphoid organ homeostasis
Steffen Jung and Dan R Littman
CD1-mediated immune responses to glycolipids
Nicolas Burdin and Mitchell Kronenberg
The role of B cells in acute and chronic infections
Martin F Bachmann and Manfred Kopf
Functions of newly identified members of the tumor
necrosis factor receptor/ligand superfamilies in
lymphocytes
Byungsuk Kwon, Byung-S Youn and Byoung S Kwon
The full text of Current Opinion in Immunology is in the
BioMedNet library at
http://BioMedNet.com/cbiology/jimm
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